Coty's Sales Slowdown Sparks Concern: Is There Still Beauty in the Numbers?

Coty (NYSE: COTY) has sent a noteworthy signal to investors, unearthing concerns over a potential slowdown in sales for its upcoming second quarter. This announcement mirrors a growing anxiety across the beauty industry about a global deceleration in market growth, which isn’t exactly what traders like to hear. Consequently, the beauty company witnessed a drop of approximately 3% in its premarket trading on Tuesday. When we examine the figures, it’s worth noting that Coty’s stock has plummeted over 26% since the beginning of the year, raising eyebrows among investors who are accustomed to a little more color in their balance sheets.

Famed for its beloved brands such as Max Factor, Covergirl, and Lancaster, Coty has reported that retailers are currently slashing inventories in response to diminishing demand for beauty products, particularly within the U.S. This shift implies that beauty shoppers might not be splurging as much as they used to, much to the dismay of those keeping a keen eye on market trends.

The company anticipated a modest 4% to 5% year-over-year increase in store sales for the fiscal first quarter ending September 30, which unfortunately falls short of the market's consensus estimate of 6%. Coty’s management has reassured the market of a “moderate” growth in sales for Q2, with expectations of a slight uptick in the latter half of the fiscal year. This optimistic view is hinged on easier comparisons from the previous year, a better sync between sell-in and sell-out strategies, fresh product launches in both the prestige and mass sectors, as well as targeted distribution expansions. It appears there's a silver lining among the clouds, but one that’s still a bit hazy.

However, the company’s anticipated Q1 EBITDA is projected to remain flat or dip slightly year-over-year, a disappointment compared to the Street’s hopes for a 6.2% increase. Still, in a positive twist, Coty did report a robust expansion in gross margins, outstripping expectations for a 50 basis point improvement.

As Coty revises its sales outlook for the year downwards, it maintained its EBITDA growth projection of 9-11%, buoyed by its ongoing cost-saving strategies. Analyzing this complex situation, analysts from Jefferies opined that the response from investors seemed to lack shock, indicating that many are already aware of the broader slowdown in the beauty sector and the tightening of retail inventories. Intriguingly, Jefferies remains optimistic about Coty's prospects, deeming it to possess value—rating it as a Buy with a valuation of 9x enterprise value (EV) to EBITDA. It seems that even amidst the gloom, some traders are still finding beauty in the numbers.